Vectura Share Discussion Threads

[pooroldboy55] 15/2/2018 14:23

Well they did get more for there money .but yes a waste .And now falling like a stone.

[blueflex2] 15/2/2018 14:16

£2.6m left from buyback. Wasted over £12m, definitely bad decision from the board.

[s1zematters] 15/2/2018 09:59

Closed my long from circa 71p yesterday at 79 plus change, the order book starting to gang up again.
Lowish volume, not convinced by the bounce.
Hope i am wrong for holders sake.

[pooroldboy55] 15/2/2018 09:00

Married well she had the money, nice girl keep telling her how lucky she is !!!!

[pooroldboy55] 15/2/2018 08:54

YES off Monday for 2 weeks to family in France. They have Internet but will keep my head down hope that works re the price.
Cheers All
POB

[richtea2517] 15/2/2018 08:29

Called marriage POB.

[cityfarmer] 15/2/2018 08:27

Morning POB’s any chance you could book another holiday? As that repeatedly does seem to mark an upward swing in the share price of VEC. Am sure that would get you in the wife’s good books too!

[pooroldboy55] 15/2/2018 08:23

Don't mind being wrong hope it stays blue but a lot of the day to go.
As for being wrong as far as the wife concerned I'm always wrong I do nothing and what I do do is wrong! !!

[richtea2517] 15/2/2018 08:17

Where's POB. Down PM?

[boadicea] 14/2/2018 21:44

Remember this?

"Short squeezes are more likely to occur in stocks with small market capitalization
and small floats, although can involve large stocks and billions of dollars, as
happened in October 2008 when a short squeeze temporarily drove the shares of
Volkswagen on the Xetra DAX from €210.85 to over €1000 in less than two days ....."
[Quote from Wikipedia]

[boadicea] 14/2/2018 21:35

The seller may be safely out of reach of uk disclosure rules, borrowing from multiple sources or even naked - who knows?
Five weeks to wait until company results but it seems unlikely that there won't be some other development before then given the current rate of attrition - even if it's only a violent reversal of the trend.

[brianbadonde] 14/2/2018 19:16

Gd bounce off lows and good volume, looking a lot better if you ask me

[muffster] 14/2/2018 17:44

Can't see who the seller is, no rns

[dontay] 14/2/2018 17:40

Yep, I got 15k at 72p... imo the fundamentals are simply on offer at a price that can't be refused. Time, as always... will tell!

[pooroldboy55] 14/2/2018 16:38

And it was so we know what tomorrow will bring.

[s1zematters] 14/2/2018 16:37

Yep another below bid close, the seller just kept increasing his amount on the book to match an corresponding buy order, the sellers amount reached nearly i million just before the UT trade at 76p
Just how many share are available to the seller is anyone's guess.
Quite a determined effort again today to drive it down.

[s1zematters] 14/2/2018 16:32

seller swamping the close auction again, let's see if a buyer is around at this level, or will it be another below bid close?

[justiceforthemany] 14/2/2018 15:48

NET CASH >£100m

[polaris] 14/2/2018 15:41

oh, and i picked up several k in the 71-73p region over lunchtime. Gift horse springs to mind for a trade.

[justiceforthemany] 14/2/2018 15:28

GlaxoSmithKline eyes $1.7B bid for respiratory partner Vectura: report
by Carly Helfand | Jan 16, 2018 12:30pm
hxxps://www.fiercepharma.com/pharma/glaxosmithkline-eyes-1-7b-bid-for-respiratory-partner-vectura-report
WHAT'S CHANGED IN LESS THAN A MONTH TO WARRANT A 45% DROP IN SHARE PRICE??!

[justiceforthemany] 14/2/2018 15:27

GlaxoSmithKline already partners with Vectura on respiratory therapies, but some say the British pharma giant could be looking to take the pair’s relationship one step further.

Glaxo is preparing a 175-pence-per-share bid for the Chippenham, U.K.-based company, sources told The Telegraph. That offer would value Vectura at close to £1.2 billion.

If GSK does strike, it’ll be taking advantage of Vectura’s 2017 share price drop. In May, the FDA turned down a generic of GlaxoSmithKline blockbuster Advair from Vectura and partner Hikma, and investors have continued to pressure the stock as they await a final verdict from the regulatory agency, due this quarter, the newspaper notes.

[rogerrail] 14/2/2018 14:58

FWIW , I think this is just trending with HIK, albeit there was a surge on takeover rumours. VEC share price has now fallen back in line, which if true shows the perception of the impact from the Advair generic is overly pessimistic.